Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Teslas long-delayed Roadster reveal and demo are driving attention, with many traders impressed by the SpaceX-inspired thruster showcase while others question its practicality, production timeline, and whether the demonstration proves the car can truly fly. The event has also fueled sell the news concerns and speculative TeslaSpaceX merger talk, but reactions to the stocks muted price action are divided.

SpaceXs pullback has traders focused on valuation concerns and the prospect that insider share unlocks could add selling pressure; some also worry that political controversy around Starlink could hurt trust in the service. Bulls are treating the decline as a buying opportunity, while merger talk with Tesla remains speculation.

Attention centers on AAOIs volatile swings and its AI data-center optics story: traders point to demand for high-speed transceivers and the completed equity sale as easing a dilution overhang, while others remain concerned about dilution, insider selling, manufacturing execution, and sharp reversals.

POETs update on customer qualification shipments, improving manufacturing yields and a planned production ramp has renewed attention, but traders are divided over whether that progress will translate into meaningful sales. Optimists point to its AI-optics partnerships and cash position, while skeptics cite the lack of confirmed scaled shipments and revenue as the stock faces heavy selling pressure.

Broadcom is caught in a semiconductor selloff as traders weigh concerns that financing costs and access to capital could constrain AI infrastructure spending, alongside questions about its exposure to major AI customers. The community is divided between seeing CEO Hock Tans warnings and related funding headlines as a threat to demand and viewing the decline as an overreaction to strong long-term custom-chip demand.

Energy Transfers agreed acquisition of Vaquero Midstream is drawing attention for expanding its Delaware Basin gas network, with traders highlighting potential growth and data-center demand. Others question the deals price and whether the company should keep making acquisitions.

Fears that Chinese rival CXMT could challenge memory-chip makers have weighed on SK Hynix alongside a broader Korean-market and semiconductor selloff, with traders also questioning the durability of AI spending. The community is split between concerns about future competition and supply pressure, and dip buyers who argue CXMTs threat is premature and point to SK Hynixs HBM position.

CIEN is drawing attention after a sharp pullback alongside other AI optical-networking stocks, with traders attributing the move to sector-wide selling and profit-taking rather than a clear company-specific catalyst. The debate is whether the decline reflects stretched valuations and crowded positioning or a buying opportunity while AI data-center connectivity demand remains strong.

Positive Phase 3 results for Moderna and Mercks personalized cancer vaccine combined with Keytruda are driving discussion, with traders debating whether Merck is getting enough credit for a partnership whose economics are shared with Moderna. Some see the oncology win as strengthening Mercks pipeline, while others question how much it changes the outlook before full data and regulatory progress.

A Melius Research upgrade to Buy, alongside other bullish analyst views, is helping drive renewed interest after CAVAs steep pullback, with some traders viewing the decline as an overreaction. The bullish case around expansion and cash generation is countered by concerns over the stocks valuation and consumer spending.